LNTH

#1009
Lantheus Holdings, Inc. - Common Stock
99.3 0 USD
-0.32%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
99.30
99.30
1年のレンジ
0.95
103.89
1日の変化
-0.32%
月次変化
+22.34%
6か月変化
+70.01%
1年の変化
+77.13%
以前の終値
99.6 2
Open
99.3 0
安値
99.3 0
High
99.3 0
ボリューム
209
チャート全体を表示 Full chart

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 6.47 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry 医薬品メーカー（特殊・ジェネリック）
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
19.52
売上高対価格比率
2.95

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

ニュース